ProfessorMarkBower

Faculty of Medicine, Faculty of Medicine Centre

Honorary Clinical Senior Lecturer

Contact

+44 (0)20 3315 8052m.bower

Location

Kobler Day CareChelsea and Westminster HospitalChelsea and Westminster Campus

Summary

Mark is a medical oncologist at Chelsea & Westminster Hospital and Professor at Imperial College who specialises in the treatment of AIDS related malignancies. He has developed one of the largest centres for the management of these tumours in Europe, receiving referrals from throughout the UK and is a key opinion leader. This service has cared for over 2,500 patients with HIV-associated cancers. His clinical research covers the epidemiology, aetiology, pathogenesis and management of these tumours. He has a laboratory programme studying the immunopathology of these tumours in collaboration with a number of basic scientists. He lectures globally and has given plenary lectures in the US, Europe, India and China.

Publications

Journals

Carbone A, Chadburn A, Gloghini A, et al.Carbone A, Chadburn A, Gloghini A, Vaccher E, Bower M close, 2024, Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management., Blood Rev, Vol:64

Pagani C, Rusconi C, Dalla Pria A, et al.Pagani C, Rusconi C, Dalla Pria A, Ravano E, Schommers P, Bastos-Oreiro M, Verga L, Gini G, Spina M, Arcaini L, Steffanoni S, Dalu D, Crucitti L, Lorenzi L, Balzarini P, Cattaneo C, Bongiovanni L, Rosenwald A, Facchetti F, Bower M, Ferreri AJM, Rossi G, Tucci A, Re A close, 2024, MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study., Blood Adv, Vol:8, Pages:968-977

Mostaghim A, Minkove S, Aguilar-Company J, et al.Mostaghim A, Minkove S, Aguilar-Company J, Ruiz-Camps I, Eremiev-Eremiev S, Dettorre GM, Fox L, Tondini C, Brunet J, Carmona-García M, Lambertini M, Bower M, Newsom-Davis T, Sharkey R, Pria AD, Rossi M, Plaja A, Salazar R, Sureda A, Prat A, Michalarea V, Van Hemelrijck M, Sita-Lumsden A, Bertuzzi A, Rimassa L, Rossi S, Rizzo G, Pedrazzoli P, Lee AJ, Murphy C, Belessiotis K, Diamantis N, Mukherjee U, Pommeret F, Stoclin A, Martinez-Vila C, Bruna R, Gaidano G, D'Avanzo F, Gennari A, Athale J, Eichacker P, Pinato DJ, Torabi-Parizi P, Cortellini A, OnCovid study group. close, 2024, Prior immune checkpoint inhibitor (ICI) therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registry, International Journal of Infectious Diseases, Vol:139, ISSN:1201-9712, Pages:13-20

Di Ciaccio PR, Polizzotto MN, Cwynarski K, et al.Di Ciaccio PR, Polizzotto MN, Cwynarski K, Gerrie AS, Burton C, Bower M, Kuruvilla J, Montoto S, McKay P, Fox CP, Milliken S, Jiamsakul A, Osborne W, Collins GP, Manos K, Linton KM, Iyengar S, Kassam S, Limei MP, Kliman D, Wong Doo N, Watson A-M, Fedele P, Yannakou CK, Hunt S, Ku M, Sehn LH, Smith A, Renshaw H, Maxwell A, Liu Q, Dhairyawan R, Ferguson G, Pickard K, Painter D, Thakrar N, Song KW, Hamad N close, 2024, The influence of immunodeficiency, disease features, and patient characteristics on survival in plasmablastic lymphoma., Blood, Vol:143, Pages:152-165

Vincenzi B, Cortellini A, Mazzocca A, et al.Vincenzi B, Cortellini A, Mazzocca A, Orlando S, Romandini D, Aguilar-Company J, Ruiz-Camps I, Valverde Morales C, Eremiev-Eremiev S, Tondini C, Brunet J, Bertulli R, Provenzano S, Bower M, Generali D, Salazar R, Sureda A, Prat A, Vasiliki M, Van Hemelrijck M, Sita-Lumsden A, Bertuzzi A, Rossi S, Jackson A, Grosso F, Lee AJX, Murphy C, Belessiotis K, Mukherjee U, Pommeret F, Loizidou A, Gaidano G, Dettorre GM, Grisanti S, Tucci M, Fulgenzi CAM, Gennari A, Napolitano A, Pinato DJ close, 2024, Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry, Therapeutic Advances in Medical Oncology, Vol:16, ISSN:1758-8340, Pages:1-11

More Publications